Current clinical protocols predominantly utilize mononuclear gadolinium(III) complexes as contrast agents. Recently, coordination clusters composed of multi-nuclear paramagnetic metal ions have demonstrated promisingly higher relaxation rates as MRI contrast agents and adaptable stability in various solutions, offering promising medical application prospects. This review mainly highlights such advancements, focusing on the influence of ligand selection and structural design on the relaxation rates of metal clusters as MRI contrast agents.